Coherus BioSciences - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsCoherus BioSciences

Coherus BioSciences(CHRS)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Loqtorzi	Toripalimab	2023-10-27		Nasopharyngeal carcinoma

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

healthy volunteers/patients

,

non-small-cell lung carcinoma

,

renal cell carcinoma

,

squamous cell carcinoma of head and neck

,

hepatocellular carcinoma

,

liver neoplasms

,

,

ovarian neoplasms

,

ovarian epithelial carcinoma

,

,

nasopharyngeal carcinoma

,

nasopharyngeal neoplasms

,

multiple myeloma

,

plasma cell neoplasms

,

,

,

precursor cell lymphoblastic leukemia-lymphoma

,

lymphoid leukemia

,

small cell lung carcinoma

,

,

,

urinary bladder neoplasms

,

esophageal squamous cell carcinoma

,

triple negative breast neoplasms

,

malignant mesothelioma

,

,

breast neoplasms

,

,

colorectal neoplasms

,

,

esophageal neoplasms

,

squamous cell carcinoma

,

pancreatic neoplasms

,

tumor virus infections

,

non-small-cell lung carcinoma

Aglatimagene besadenovec

,

triple negative breast neoplasms

,

pharmacokinetics

,

healthy volunteers/patients

,

pharmacological phenomena

,

,

breast neoplasms

,

,

neoplasm metastasis

,

,

ovarian neoplasms

,

non-small-cell lung carcinoma

,

pancreatic neoplasms

,

colorectal neoplasms

,

,

uterine cervical neoplasms

,

endometrial neoplasms

,

stomach neoplasms

,

urinary bladder neoplasms

,

small cell lung carcinoma

,

biliary tract neoplasms

,

,

,

hereditary breast and ovarian cancer syndrome

,

,

head and neck neoplasms

,

dna repair-deficiency disorders

,

,

ovarian epithelial carcinoma

,

,

hypersensitivity

,

,

prostatic neoplasms

,

castration-resistant prostatic neoplasms

,

,

coronary disease

,

coronary artery disease

,

myocardial ischemia

,

,

,

,

disease susceptibility

,

hepatocellular carcinoma

,

liver neoplasms

colorectal neoplasms

,

pancreatic neoplasms

,

Microcrystalline cellulose

,

ovarian neoplasms

,

serous cystadenocarcinoma

,

fallopian tube neoplasms

,

,

hereditary breast and ovarian cancer syndrome

,

mullerian mixed tumor

,

,

,

myeloid leukemia acute

,

precursor cell lymphoblastic leukemia-lymphoma

,

myeloid leukemia

,

precursor t-cell lymphoblastic leukemia-lymphoma

,

,

lymphoid leukemia

ovarian neoplasms

,

fallopian tube neoplasms

,

ovarian epithelial carcinoma

,

peritoneal neoplasms

,

endometrial neoplasms

myeloid leukemia acute

,

colorectal neoplasms

,

ovarian neoplasms

,

triple negative breast neoplasms

,

small cell lung carcinoma

,

myeloid leukemia

,

biliary tract neoplasms

,

follicular lymphoma

,

,

,

cytomegalovirus retinitis

,

,

non-hodgkin lymphoma

,

,

falciparum malaria

,

,

penile induration

,

retinal vein occlusion

,

,

macular degeneration

,

,

,

epiretinal membrane

,

,

muscle spasticity

1

2

>

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use